Iterum Therapeutics
ITRM
$1.53
Share price
-0.65%
Change (1 day)
31.90%
Change (1 year)
Categories
Iterum Therapeutics (ITRM) - P/B ratio
P/B ratio as of May 2024 : -3.93
According to Iterum Therapeutics's latest financial reports the company has a price-to-book ratio of -3.93.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Iterum Therapeutics - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -4.13 | -1226.29% |
| 2022-12-31 | 0.3670 | -74.25% |
| 2021-12-31 | 1.43 | -248.48% |
| 2020-12-31 | -0.9601 | -62.35% |
| 2019-12-31 | -2.55 | -357.47% |
| 2018-12-31 | 0.9905 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.66 | -167.68% | 🇺🇸 USA |